News
Videos
Conferences
Events
Resources
Subscribe

|Videos|September 22, 2017

Making Treatment Decisions When Cancer Recurs

Newsletter

Stay up to date on cancer updates, research and education

Related Content

FDA Approves Stoboclo and Osenvelt as Biosimilars for Some Cancers

BySpencer Feldman

November 3rd 2025

Choosing treatment for stage 2 prostate cancer? Get the facts on surgery vs. radiation and learn to manage possible side effects like erectile dysfunction.

What Does a Stage 2 Prostate Cancer Diagnosis Mean for Me?

November 2nd 2025

prostate cancer

Alternative Docetaxel Dosing Reduces Toxicity Risk in Prostate Cancer

ByBenjamin P. Saylor

October 22nd 2025

Image of Prostate.

Supplemental Xtandi Does Not Improve Metastasis-Free Survival in High-Risk Prostate Cancer

October 19th 2025

Adding Truqap to Zytiga, prednisone, and ADT extended radiographic progression-free survival by 7.5 months in PTEN-deficient prostate cancer.

Truqap Extends Radiographic Progression-Free Survival in Some With Prostate Cancer

October 19th 2025

Trending on CURE

Understanding Your Diagnosis of Bile Duct Cancer

Top Blood Cancer Stories from October: Key Updates for Patients

Understanding Your Stage 2 Uterine (Endometrial) Cancer

Understanding Your Diagnosis: Stage 2 Oral Cavity Cancer

Understanding Thymoma Cancer and Its Treatment Options: A Patient Guide

© 2025 MJH Life Sciences^®

All rights reserved.